Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

Martinez C, Assimes TL, Mines D, Dell'aniello S, Suissa S.

BMJ. 2010 Feb 5;340:c249. doi: 10.1136/bmj.c249.

2.

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

Rubino A, Roskell N, Tennis P, Mines D, Weich S, Andrews E.

BMJ. 2007 Feb 3;334(7587):242. Epub 2006 Dec 12.

3.

Treatment with duloxetine in adults and the incidence of cardiovascular events.

Xue F, Strombom I, Turnbull B, Zhu S, Seeger J.

J Clin Psychopharmacol. 2012 Feb;32(1):23-30. doi: 10.1097/JCP.0b013e31823fb238.

PMID:
22198454
6.

Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study.

Weeke P, Jensen A, Folke F, Gislason GH, Olesen JB, Andersson C, Fosbøl EL, Larsen JK, Lippert FK, Nielsen SL, Gerds T, Andersen PK, Kanters JK, Poulsen HE, Pehrson S, Køber L, Torp-Pedersen C.

Clin Pharmacol Ther. 2012 Jul;92(1):72-9. doi: 10.1038/clpt.2011.368. Epub 2012 May 16.

PMID:
22588605
7.

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.

Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J.

Arch Gen Psychiatry. 2006 Dec;63(12):1358-67.

PMID:
17146010
8.

Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care.

Hippisley-Cox J, Pringle M, Hammersley V, Crown N, Wynn A, Meal A, Coupland C.

BMJ. 2001 Sep 22;323(7314):666-9.

9.

Prevalence of sexual dysfunction among newer antidepressants.

Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A.

J Clin Psychiatry. 2002 Apr;63(4):357-66.

PMID:
12000211
10.

Cyclic antidepressants and the risk of sudden cardiac death.

Ray WA, Meredith S, Thapa PB, Hall K, Murray KT.

Clin Pharmacol Ther. 2004 Mar;75(3):234-41.

PMID:
15001975
11.

Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.

Mines D, Hill D, Yu H, Novelli L.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):367-72.

PMID:
15883980
12.

Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.

Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ.

Drug Saf. 2015 Dec;38(12):1187-99. doi: 10.1007/s40264-015-0338-0.

13.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
14.

Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.

de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S.

Br J Clin Pharmacol. 2000 Jul;50(1):43-7.

15.

Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study.

Chen Y, Guo JJ, Li H, Wulsin L, Patel NC.

Ann Pharmacother. 2008 Feb;42(2):177-84. doi: 10.1345/aph.1K369. Epub 2008 Jan 22.

PMID:
18212255
16.

Clinical evaluation of venlafaxine.

Ballenger JC.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):29S-35S; discussion 35S-36S. Review.

PMID:
8784646
17.

Venlafaxine: a 2003 update.

Gutierrez MA, Stimmel GL, Aiso JY.

Clin Ther. 2003 Aug;25(8):2138-54. Review.

PMID:
14512125
18.

Population-based studies of antithyroid drugs and sudden cardiac death.

van Noord C, Sturkenboom MC, Straus SM, Hofman A, Witteman JC, Stricker BH.

Br J Clin Pharmacol. 2009 Sep;68(3):447-54. doi: 10.1111/j.1365-2125.2009.03474.x.

19.

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.

Schlienger RG, Fischer LM, Jick H, Meier CR.

Drug Saf. 2004;27(14):1157-65.

PMID:
15554748
20.

[Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?].

Bramness JG, Engeland A, Furu K.

Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2653-5. Norwegian.

Supplemental Content

Support Center